Literature DB >> 26387934

Is the time interval between HCG administration and oocyte retrieval associated with oocyte retrieval rate?

Julia K Bosdou1, Efstratios M Kolibianakis2, Christos A Venetis3, Leonidas Zepiridis2, Katerina Chatzimeletiou2, Anastasios Makedos2, Stylianos Triantafyllidis2, Sevasti Masouridou2, Anna Mitsoli2, Basil Tarlatzis2.   

Abstract

The aim of this study was to evaluate whether prolongation of the time interval between HCG administration and oocyte retrieval, from 36 h to 38 h, affects oocyte retrieval rate in women undergoing ovarian stimulation with gonadotrophins and GnRH antagonists for IVF. One hundred and fifty-six normo-ovulatory women were randomized to have oocyte retrieval performed 36 h (n = 78) or 38 h (n = 78) following HCG administration. Oocyte retrieval rate was defined as number of cumulus-oocyte-complex (COC) retrieved/follicle ≥ 11 mm present on day of HCG administration. No significant differences were observed between the groups regarding baseline characteristics. Moreover, no significant difference was observed between the groups regarding oocyte retrieval rate (difference: + 1.2%, 95% CI for difference between medians: -4.5 to +12.1). The median (95% CI for the median) was not significantly different between the groups regarding number of cumulus-oocyte-complexes (COCs) retrieved: 5.5 (5.0-7.0) versus 6.0 (5.0-6.2), respectively, and fertilization rates: 57.7% (50.0-66.7) versus 50.0% (44.8-65.5), respectively. Live birth rates were similar between the groups (20.5% versus 16.7%, RD: + 3.8%, 95% CI: -8.5 to +16.1, respectively). Prolongation of time interval between HCG administration and oocyte retrieval from 36 h to 38 h does not affect oocyte retrieval rate.
Copyright © 2015 Reproductive Healthcare Ltd. Published by Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  antagonists; gonadotropins; oocyte retrieval rate; ovarian stimulation; randomized clinical trial

Mesh:

Substances:

Year:  2015        PMID: 26387934     DOI: 10.1016/j.rbmo.2015.08.005

Source DB:  PubMed          Journal:  Reprod Biomed Online        ISSN: 1472-6483            Impact factor:   3.828


  5 in total

Review 1.  Novel Concepts for Inducing Final Oocyte Maturation in In Vitro Fertilization Treatment.

Authors:  Ali Abbara; Sophie A Clarke; Waljit S Dhillo
Journal:  Endocr Rev       Date:  2018-10-01       Impact factor: 19.871

2.  The ovulation trigger-OPU time interval of different ovarian protocols in ART: a retrospective study.

Authors:  Xi Shen; Hui Long; Wenya Guo; Yating Xie; Hongyuan Gao; Jie Zhang; Yun Wang; Qifeng Lyu; Yanping Kuang; Li Wang
Journal:  Arch Gynecol Obstet       Date:  2020-06-03       Impact factor: 2.344

3.  A Higher Estradiol Rise After Dual Trigger in Progestin-Primed Ovarian Stimulation Is Associated With a Lower Oocyte and Mature Oocyte Yield in Normal Responders.

Authors:  Jialyu Huang; Xuefeng Lu; Jiaying Lin; Ningling Wang; Qifeng Lyu; Hongyuan Gao; Renfei Cai; Yanping Kuang
Journal:  Front Endocrinol (Lausanne)       Date:  2019-10-09       Impact factor: 5.555

4.  The optimal period for oocyte retrieval after the administration of recombinant human chorionic gonadotropin in in vitro fertilization.

Authors:  Mhd Jawad Al Rahwanji; Homam Abouras; Mhd Said Shammout; Ray Altalla; Reem Al Sakaan; Nawras Alhalabi; Marwan Alhalabi
Journal:  BMC Pregnancy Childbirth       Date:  2022-03-07       Impact factor: 3.007

5.  The Maribor consensus: report of an expert meeting on the development of performance indicators for clinical practice in ART.

Authors:  Veljko Vlaisavljevic; Susanna Apter; Antonio Capalbo; Arianna D'Angelo; Luca Gianaroli; Georg Griesinger; Efstratios M Kolibianakis; George Lainas; Tonko Mardesic; Tatjana Motrenko; Sari Pelkonen; Daniela Romualdi; Nathalie Vermeulen; Kelly Tilleman
Journal:  Hum Reprod Open       Date:  2021-07-03
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.